These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 16890021)

  • 1. Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
    Marr AK; Gooderham WJ; Hancock RE
    Curr Opin Pharmacol; 2006 Oct; 6(5):468-72. PubMed ID: 16890021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.
    Hancock RE; Sahl HG
    Nat Biotechnol; 2006 Dec; 24(12):1551-7. PubMed ID: 17160061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial peptides: their physicochemical properties and therapeutic application.
    Kang SJ; Kim DH; Mishig-Ochir T; Lee BJ
    Arch Pharm Res; 2012 Mar; 35(3):409-13. PubMed ID: 22477186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
    Conlon JM; Galadari S; Raza H; Condamine E
    Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches in peptide antibiotics.
    Vaara M
    Curr Opin Pharmacol; 2009 Oct; 9(5):571-6. PubMed ID: 19734091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris.
    Marta Guarna M; Coulson R; Rubinchik E
    FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
    Rubinchik E; Dugourd D; Algara T; Pasetka C; Friedland HD
    Int J Antimicrob Agents; 2009 Nov; 34(5):457-61. PubMed ID: 19524411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
    Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
    Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are antimicrobial peptides an alternative for conventional antibiotics?
    Kamysz W
    Nucl Med Rev Cent East Eur; 2005; 8(1):78-86. PubMed ID: 15977155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides.
    Haug BE; Stensen W; Stiberg T; Svendsen JS
    J Med Chem; 2004 Aug; 47(17):4159-62. PubMed ID: 15293987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.
    Parisien A; Allain B; Zhang J; Mandeville R; Lan CQ
    J Appl Microbiol; 2008 Jan; 104(1):1-13. PubMed ID: 18171378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents.
    Conlon JM; Al-Ghaferi N; Abraham B; Leprince J
    Methods; 2007 Aug; 42(4):349-57. PubMed ID: 17560323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics.
    Cassone M; Otvos L
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):703-16. PubMed ID: 20521897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
    Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
    J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cationic antimicrobial peptides: from innate immunity study to drug development. Up date].
    Andrès E; Dimarcq JL
    Med Mal Infect; 2007 Apr; 37(4):194-9. PubMed ID: 17306486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic application of host defense peptides.
    Zhang L; Falla TJ
    Methods Mol Biol; 2010; 618():303-27. PubMed ID: 20094872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic antimicrobial peptidomimetics with therapeutic potential.
    Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
    J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.